The theracyte™ device protects against islet allograft rejection in immunized hosts

Cell Transplantation

Volumn 22, Issue 7, 2013, Pages 1137-1146

  Kumagai Braesch, Makiko ^a   Jacobson, Stella ^a   Mori, Hiroki ^a   Jia, Xiaohui ^a   Takahashi, Tohru ^a   Wernerson, Annika ^a   Flodström Tullberg, Malin ^a   Tibell, Annika ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Alloantibodies; Device; IFN ELISpot; Immunized recipients; Islet transplantation; Macroencapsulation; TheraCyte

Indexed keywords

GAMMA INTERFERON; GLUCOSE; INSULIN;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INSULIN BLOOD LEVEL; KIDNEY CAPSULE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GLUCOSE TOLERANCE TEST; GRAFT REJECTION; INSULIN; INTERFERON-GAMMA; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; ISOANTIBODIES; RATS; RATS, INBRED LEW; RATS, INBRED WF; TRANSPLANTATION, HOMOLOGOUS;

RATTUS;

EID: 84879591641     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657486     Document Type: Article

References (25)

1. Brauker, J. H.; Carr-Brendel, V. E.; Martinson, L. A.; Crudele, J.; Johnston, W. D.; Johnson, R. C. Neovascularization of synthetic membranes directed by membrane microarchitecture. J. Biomed. Mater. Res. 29:1517-1524; 1995.
2. Brauker, J. H.; Martinson, L. A.; Young, S. K.; Johnson, R. C. Local inflammatory response around diffusion chambers containing xenografts. Nonspecific destruction of tissues and decreased local vascularization. Transplantation 61:1671-1677; 1996.
3. Campbell, P. M.; Senior, P. A.; Salam, A.; Labranche, K.; Bigam, D. L.; Kneteman, N. M.; Imes, S.; Halpin, A.; Ryan, E. A.; Shapiro, A. M. J. High risk of sensitization after failed islet transplantation. Am. J. Transplant. 7:2311-2317; 2007.
4. Cornolti, R.; Cattaneo, I.; Trudu, M.; Figliuzzi, M.; Remuzzi, A. Effect of islet transplantation on metabolic glucose control in rats with diabetes. Diabetes Technol. Ther. 11:805-811; 2009.
5. Harlan, D. M.; Kenyon, N. S.; Korsgren, O.; Roep, B. O. Current advances and travails in islet transplantation. Diabetes 58:2175-2184; 2009.
6. Jackson, A. M.; Connolly, J. E.; Matsumoto, S.; Noguchi, H.; Onaca, N.; Levy, M. F.; Naziruddin, B. Evidence for induced expression of HLA class II on human islets: Possible mechanism for HLA sensitization in transplant recipients. Transplantation 87:500-506; 2009.
7. Jia, X.; Sharma, A.; Kumagai-Braesch, M.; Wernerson, A. M.; Sörenby, A. K.; Yamamoto, S.; Wang, F.; Tibell, A. B. Exendin-4 increases the expression of hypoxia-inducible factor-1a in rat islets and preserves the endocrine-cell volume of both free an macroencapsulated islet grafts. Cell Transplant. 21(6):1269-1283; 2012.
8. Jones, K. S.; Sefton, M. V.; Gorczynski, R. M. In vivo recognition by the host adaptive immune system of microencapsulated xenogeneic cells. Transplantation 78:1454-1462; 2004.
9. Kessler, L.; Parissiadis, A.; Bayle, F.; Moreau, F.; Pinget, M.; Froelich, N.; Cazenave, J. P.; Berney, T.; Benhamou, P. Y.; Hanau, D. Evidence for humoral rejection of a pancreatic islet graft and rescue with rituximab and iv immunoglobulin therapy. Am. J. Transplant. 9:1961-1966; 2009.
10. Loudovaris, T.; Charlton, B.; Hodgson, R. J.; Mandel, T. E. Destruction of xenografts but not allografts within cell impermeable membranes. Transplant. Proc. 24:2291-2292; 1992.
11. Loudovaris, T.; Mandel, T. E.; Charlton, B. CD4+ T-cell mediated destruction of xenografts within cell-impermeable membranes in the absence of CD8+ T-cells and B-cells. Transplantation 61:1678-1684; 1996.
12. McKenzie, A. W.; Georgiou, H. M.; Zhan, Y.; Brady, J. L.; Lew, A. M. Protection of xenografts by a combination of immunoisolation and a single dose of anti-CD4 antibody. Cell Transplant. 10:183-193; 2001.
13. Merville, P.; Pouteil-Noble, C.; Wijdenes, J.; Potaux, L.; Touraine, J. L.; Banchereau, J. Detection of single cells secreting IFN-g, IL-6, and IL-10 in irreversibly rejected human kidney allografts, and their modulation by IL-2 and IL-4. Transplantation 55:639-646; 1993.
14. Pathan, A. A.; Wilkinson, K. A.; Wilkinson, R. J.; Latif, M.; McShane, H.; Pasvol, G.; Hill, A. V.; Lalvani, A. High frequencies of circulating IFN-g-secreting CD8 cytotoxic T-cells specific for a novel MHC class I-restricted mycobacterium tuberculosis epitope in m. Tuberculosis-infected subjects without disease. Eur. J. Immunol. 30:2713-2721; 2000.
15. Rafael, E.; Wu, G. S.; Hultenby, K.; Tibell, A.; Wernerson, A. Improved survival of macroencapsulated islets of Langerhans by preimplantation of the immunoisolating device: A morphometric study. Cell Transplant. 12:407-412; 2003.
16. Ryan, E. A.; Paty, B. W.; Senior, P. A.; Bigam, D.; Alfadhli, E.; Kneteman, N. M.; Lakey, J. R.; Shapiro, A. M. Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069; 2005.
17. Safley, S. A.; Kapp, J. A.; Weber, C. J. Proliferative and cytokine responses in CTLA4-Ig-treated diabetic NOD mice transplanted with microencapsulated neonatal porcine ICCs. Cell Transplant. 11:695-705; 2002.
18. Sharma, A.; Sorenby, A.; Wernerson, A.; Efendic, S.; Kumagai-Braesch, M.; Tibell, A. Exendin-4 treatment improves metabolic control after rat islet transplantation to athymic mice with streptozotocin-induced diabetes. Diabetologia 49:1247-1253; 2006.
19. Sorenby, A. K.; Kumagai-Braesch, M.; Sharma, A.; Hultenby, K. R.; Wernerson, A. M.; Tibell, A. B. Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: Studies in a rodent model. Transplantation 86:364-366; 2008.
20. Sorenby, A. K.; Wu, G. S.; Zhu, S.; Wernerson, A. M.; Sumitran-Holgersson, S.; Tibell, A. B. Macroencapsulation protects against sensitization after allogeneic islet transplantation in rats. Transplantation 82:393-397; 2006.
21. Sweet, I. R.; Yanay, O.; Waldron, L.; Gilbert, M.; Fuller, J. M.; Tupling, T.; Lernmark, A.; Osborne, W. R. Treatment of diabetic rats with encapsulated islets. J. Cell. Mol. Med. 12:2644-2650; 2008.
22. Tibell, A.; Rafael, E.; Wennberg, L.; Nordenstrom, J.; Bergstrom, M.; Geller, R. L.; Loudovaris, T.; Johnson, R. C.; Brauker, J. H.; Neuenfeldt, S.; Wernerson, A. Survival of macroencapsulated allogeneic parathyroid tissue one year after transplantation in nonimmunosuppressed humans. Cell Transplant. 10:591-599; 2001.
23. Toso, C.; McCall, M.; Emamaullee, J.; Merani, S.; Davis, J.; Edgar, R.; Pawlick, R.; Kin, T.; Knudsen, L. B.; Shapiro, A. M. Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transpl. Int. 23:259-265; 2010.
24. Weibel, E. R. Morphometry of the human lung: The state of the art after two decades. Bull. Eur. Physiopathol. Respir. 15:999-1013; 1979.
25. Yang, Z.; Chen, M.; Fialkow, L. B.; Ellett, J. D.; Wu, R.; Nadler, J. L. Survival of pancreatic islet xenografts in NOD mice with the theracyte device. Transplant. Proc. 34:3349-3350; 2002.